SelectTech Dumbells

Medifast, Inc. (NYSE: MED) today announced that a recent study published in ‘The Journal of Eating and Weight Disorders’ shows that individuals taking appetite suppressant medications can expect double the weight loss when they combine their drug therapy with a medical protocol using Medifast Meal Replacement Supplements.

The 52-week study, conducted by researchers at the University of Missouri-Kansas City School of Medicine and Baylor College of Medicine shows that participants who consistently used Medifast Meal Replacements along with pharmacotherapy lost an average of 14% of their body weight in one year. This amount of weight loss is approximately double what is seen in university studies of obesity medications alone over the same time frame. In the study, more than 80% of the participants lost at least 5% of their body weight, which is more than double that found for other structured commercial weight loss programs.

“The results of studies featuring Medifast Meal Replacements are superior to those typically observed for other obesity interventions including weight loss medications and other commercial weight loss plans,” says Lisa M. Davis, Ph.D., PA-C, C.N.S., L.D.N., Director of Research and Development, Medifast, Inc. “This suggests that comprehensive weight control programs featuring Medifast provide a unique solution for weight control.”

While the Company does not advocate the use of weight loss drugs, Medifast does recognize that diet pills are part of the weight loss landscape now and are likely to remain so in the future. Medifast is a proven weight control program in and of itself, and has now been shown to double the results of comprehensive weight control programs employing appetite suppressant medications.

Medifast will continually participate in studies in the future, which will add even more credibility to the Brand and its Programs. For more than 25 years Medifast has been prescribed by practitioners as a safe and effective program that has been clinically proven to yield significant weight loss of 2-5 pounds per week.

Since 1980, 15,000 physicians from across the country have trusted Medifast to provide their patients with the highest quality, nutritious weight loss and disease management solutions.

MED-G

About Medifast:

Medifast (NYSE: MED) is the leading easy-to-use, clinically proven portion-controlled weight loss program. Medifast has been recommended by 15,000 physicians and used by over one million customers. Medifast is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape For Life direct-selling division, a network of health coaches, 3) medically supervised Medifast Weight Control Centers, and 4) national network of physicians. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto http://www.choosemedifast.com.

SOURCE Medifast, Inc. / PRNewswire

Post to Twitter Post to Delicious Post to Digg Post to Facebook